Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 1, 2017

DrugPatentWatch Database Preview

Isoniazid - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for isoniazid and what is the scope of isoniazid patent protection?

is the generic ingredient in eleven branded drugs marketed by Watson Labs, Ivax Sub Teva Pharms, Thepharmanetwork Llc, Hikma Intl Pharms, Mikart, Duramed Pharms Barr, Roche, Whiteworth Town Plsn, Everylife, Panray, Dow Pharm, Halsey, Purepac Pharm, Sun Pharm Inds, Medpointe Pharm Hlc, Carolina Medcl, Novartis, Barr, Lannett, Mk Labs, Sandoz Inc, Nexgen Pharma Inc, Impax Labs, Perrigo, Sandoz, Phoenix Labs Ny, Pharmavite, Bristol Myers Squibb, Lilly, and Sanofi Aventis Us, and is included in forty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for isoniazid. Thirty-two suppliers are listed for this compound.

Summary for Generic Name: isoniazid

Drug Master File Entries: see list5
Suppliers / Packagers: see list32
Bulk Api Vendors: see list86
Clinical Trials: see list40
Patent Applications: see list8,335
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:isoniazid at DailyMed

Pharmacology for Ingredient: isoniazid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
TABLET;ORAL008392-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Thepharmanetwork Llc
TABLET;ORAL202610-001Oct 29, 2014AARXNoNo► Subscribe► Subscribe
Whiteworth Town Plsn
TABLET;ORAL080120-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL080935-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Duramed Pharms Barr
TABLET;ORAL088119-001Mar 17, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus